Followers | 144 |
Posts | 10941 |
Boards Moderated | 0 |
Alias Born | 04/02/2006 |
Wednesday, September 28, 2016 5:47:52 PM
Date Published: 2016-09-27
PREFACE
Exelixis, Inc. (NASDAQ:EXEL) revenue over a trailing-twelve-month period is trending higher which means it is increasing for at least four consecutive quarters. In the revenue time series chart below, we can see the data.
The bars plot the exploding revenue for Exelixis, Inc.. We define 'exploding' as a revenue trend that shows at least 30% growth over the last year and at least 75% growth over the last two-years. EXEL revenue meets both of those requirements. Feel free to hover over the chart to see the actual values for Exelixis, Inc..
BARS: EXEL Revenue
Exelixis, Inc. (NASDAQ:EXEL) has shown a 130.37% year-over-year revenue change and 235.86% two-year change. When a company grows revenue this quickly, shows positive two-year revenue growth and is trending consecutively higher, top line growth may supersede earnings and free cash flow in the short to intermediate term. If revenue stays trending, Exelixis, Inc. could find net income and cash from operations growing rapidly in the near future.
While revenue for Exelixis, Inc. (NASDAQ:EXEL) is trending higher, we note that net income is still negative over the last year. All things are forgiven when revenue stays trending higher, but there is serious risk to the stock price for EXEL if the revenue trend hits a wall while earnings stays negative. We do note the criticality of cash from operations, which is in fact positive for Exelixis, Inc. (NASDAQ:EXEL) even with negative earnings.
Here is a more myopic view of the exploding revenue data in tabular format for the last two-years:
EXEL
Two-Years Ago : $21 million
One-Year Ago : $31 million
Current : $71 million
http://news.cmlviz.com/2016/09/27/trending-exelixis-inc-revenue-is-exploding-higher.html
Recent EXEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:05:43 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/08/2024 08:11:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 10:19:20 PM
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May • Business Wire • 05/07/2024 08:05:00 PM
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update • Business Wire • 04/30/2024 08:05:00 PM
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 • Business Wire • 04/16/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:59:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:58:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:58:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:58:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:58:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:58:01 PM
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March • Business Wire • 02/27/2024 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 11:33:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:08:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 12:21:07 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 02:19:48 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/06/2024 09:49:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:28:36 PM
- Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update • Business Wire • 02/06/2024 09:05:00 PM
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February • Business Wire • 02/01/2024 09:05:00 PM
- Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024 • Business Wire • 01/25/2024 01:00:00 PM
- Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024 • Business Wire • 01/23/2024 09:05:00 PM
- Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma • Business Wire • 01/22/2024 10:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM